Infectious Disease

Clearing the Path: A Roadmap to COVID-19 Vaccine Acceptance through the Simple Presumptive Offering

The COVID-19 pandemic has continued to evolve since the first case was seen in the United States in 2020. Over the course of the last 3 years, the United States and the world have lost millions of people from this virus with many more millions hospitalized.1 [1A,P2] COVID-19 vaccines were introduced in late 2020 and have had a significant impact on the pandemic trajectory. Estimates are that between December 8, 2020, and December 8, 2021, the vaccines have prevented at least 14.4 million COVID-19 related deaths in 185 countries.2 [2A,P1]
The initial acceptance of the COVID-19 vaccine was very high with close to 4 in 5 American adults completing their primary series.3[3A,P6] With the introduction of subsequent vaccine doses to address the new variants and waning immunity, the overall uptake has been much lower. Only 1 in 5 American adults have received the bivalent vaccine dose.3[3a B,P5] With the introduction of a new vaccine formulation in fall 2023, it is important for healthcare professionals to raise vaccine confidence to ensure their patients, especially those at high-risk, have optimal protection against COVID-19. This program focuses on improving vaccine confidence by helping you deliver presumptive recommendations, address questions and misinformation.

Take this Course
Free

DURATION

30 min

PROFESSION

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

# OF CREDITS

0

ACCREDITATION

Unaccredited

EXPIRY DATE

2024-09-22

The COVID-19 pandemic has continued to evolve since the first case was seen in the United States in 2020. Over the course of the last 3 years, the United States and the world have lost millions of people from this virus with many more millions hospitalized.1 [1A,P2] COVID-19 vaccines were introduced in late 2020 and have had a significant impact on the pandemic trajectory. Estimates are that between December 8, 2020, and December 8, 2021, the vaccines have prevented at least 14.4 million COVID-19 related deaths in 185 countries.2 [2A,P1]
The initial acceptance of the COVID-19 vaccine was very high with close to 4 in 5 American adults completing their primary series.3[3A,P6] With the introduction of subsequent vaccine doses to address the new variants and waning immunity, the overall uptake has been much lower. Only 1 in 5 American adults have received the bivalent vaccine dose.3[3a B,P5] With the introduction of a new vaccine formulation in fall 2023, it is important for healthcare professionals to raise vaccine confidence to ensure their patients, especially those at high-risk, have optimal protection against COVID-19. This program focuses on improving vaccine confidence by helping you deliver presumptive recommendations, address questions and misinformation.

Faculty

  • Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP 
  •  Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN 
  •  Jeffery A. Goad, PharmD, MPH 
  •  Lauren B. Angelo, PharmD, MBA 
  •  William A. Fisher, PhD, FRSC 
  •  Jared Auclair, PhD

Learning objectives

Upon completion of this continuing education program, participants will be better able to:

  • Discuss a time-efficient approach for vaccine communication.
  • Use the presumptive offer to enhance vaccine communication with patients.
  • Determine how the presumptive offer can help to address both patient and healthcare barriers to COVID-19 uptake.

Accreditation

Individuals who complete this training module will receive an emailed Northeastern University Learning Credential or badge shortly following the completion of the course. A digital badge serves as a credential that includes meta data around what was learned and successful completion of the content provided.

Take this Course
Cost of course:  
Free
# of credits: 0
Duration: 30 min

RELATED COURSES

Respirology
RSV Prevention for All Infants: From NACI Guidelines to Clinical Application
Accreditation : Unaccredited
Credits : 0
Duration : 15 min
Free
Travel Medicine
(Pharmacists) Chikungunya Essentials: A Guide to Prevention and Management
Accreditation : CCCEP, OPQ
Credits : 2
Duration : 45 min
Free
Travel Medicine
(Physicians) Chikungunya Essentials: A Guide to Prevention and Management
Accreditation : Mainpro+
Credits : 0.75
Duration : 45 min
Free

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

VYF-University Logo
Northern University Logo
Infectious Disease
Clearing the Path: A Roadmap to COVID-19 Vaccine Acceptance through the Simple Presumptive Offering

The COVID-19 pandemic has continued to evolve since the first case was seen in the United States in 2020. Over the course of the last 3 years, the United States and the world have lost millions of people from this virus with many more millions hospitalized.1 [1A,P2] COVID-19 vaccines were introduced in late 2020 and have had a significant impact on the pandemic trajectory. Estimates are that between December 8, 2020, and December 8, 2021, the vaccines have prevented at least 14.4 million COVID-19 related deaths in 185 countries.2 [2A,P1]
The initial acceptance of the COVID-19 vaccine was very high with close to 4 in 5 American adults completing their primary series.3[3A,P6] With the introduction of subsequent vaccine doses to address the new variants and waning immunity, the overall uptake has been much lower. Only 1 in 5 American adults have received the bivalent vaccine dose.3[3a B,P5] With the introduction of a new vaccine formulation in fall 2023, it is important for healthcare professionals to raise vaccine confidence to ensure their patients, especially those at high-risk, have optimal protection against COVID-19. This program focuses on improving vaccine confidence by helping you deliver presumptive recommendations, address questions and misinformation.

Accreditation

Individuals who complete this training module will receive an emailed Northeastern University Learning Credential or badge shortly following the completion of the course. A digital badge serves as a credential that includes meta data around what was learned and successful completion of the content provided.

Category:

Infectious Disease

Accreditation:

Unaccredited

Duration :

30 min

Expiry Date:

2024-09-22

Profession:

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

Number of Credits:

Faculty

  • Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP 
  •  Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN 
  •  Jeffery A. Goad, PharmD, MPH 
  •  Lauren B. Angelo, PharmD, MBA 
  •  William A. Fisher, PhD, FRSC 
  •  Jared Auclair, PhD

Learning Objectives

Upon completion of this continuing education program, participants will be better able to:

  • Discuss a time-efficient approach for vaccine communication.
  • Use the presumptive offer to enhance vaccine communication with patients.
  • Determine how the presumptive offer can help to address both patient and healthcare barriers to COVID-19 uptake.
VYF-University Logo
Northeastern-University-Logo-e1695152692691.png
© 2024 All Rights Reserved MDBriefCase, a Think Research Company.

  Privacy Policy. Terms of Service

Take this Course